Authors:
RALHAN R
NATH N
AGARWAL S
MATHUR M
WASYLYK B
SHUKLA NK
Citation: R. Ralhan et al., CIRCULATING P53 ANTIBODIES AS EARLY MARKERS OF ORAL-CANCER - CORRELATION WITH P53 ALTERATIONS, Clinical cancer research, 4(9), 1998, pp. 2147-2152
Citation: B. Wasylyk et al., ETS TRANSCRIPTION FACTORS - NUCLEAR EFFECTORS OF THE RAS-MAP-KINASE SIGNALING PATHWAY, Trends in biochemical sciences, 23(6), 1998, pp. 213-216
Authors:
LEVEILLARD T
GORRY P
NIEDERREITHER K
WASYLYK B
Citation: T. Leveillard et al., MDM2 EXPRESSION DURING MOUSE EMBRYOGENESIS AND THE REQUIREMENT OF P53, Mechanisms of development, 74(1-2), 1998, pp. 189-193
Authors:
GOLDMAN D
SAPRU MK
STEWART S
PLOTKIN J
LIBERMANN TA
WASYLYK B
GUAN K
Citation: D. Goldman et al., CLONING AND CHARACTERIZATION OF GETS-1, A GOLDFISH ETS FAMILY MEMBER THAT FUNCTIONS AS A TRANSCRIPTIONAL REPRESSOR IN MUSCLE, Biochemical journal, 335, 1998, pp. 267-275
Citation: L. Andera et B. Wasylyk, TRANSCRIPTION ABNORMALITIES POTENTIATE APOPTOSIS OF NORMAL HUMAN FIBROBLASTS, Molecular medicine, 3(12), 1997, pp. 852-863
Citation: Sl. Hahn et al., MODULATION OF ETS-1 TRANSCRIPTIONAL ACTIVITY BY HUUBC9, A UBIQUITIN-CONJUGATING ENZYME, Oncogene, 15(12), 1997, pp. 1489-1495
Authors:
WASYLYK C
BRADFORD AP
GUTIERREZHARTMANN A
WASYLYK B
Citation: C. Wasylyk et al., CONSERVED MECHANISMS OF RAS REGULATION OF EVOLUTIONARY RELATED TRANSCRIPTION FACTORS, ETS1 AND POINTED P2, Oncogene, 14(8), 1997, pp. 899-913
Authors:
BRADFORD AP
WASYLYK C
WASYLYK B
GUTIERREZHARTMANN A
Citation: Ap. Bradford et al., INTERACTION OF ETS-1 AND THE POU-HOMEODOMAIN PROTEIN GHF-1 PIT-1 RECONSTITUTES PITUITARY-SPECIFIC GENE-EXPRESSION/, Molecular and cellular biology, 17(3), 1997, pp. 1065-1074
Authors:
GIOVANE A
SOBIESZCZUK P
AYADI A
MAIRA SM
WASYLYK B
Citation: A. Giovane et al., NET-B, A RAS-INSENSITIVE FACTOR THAT FORMS TERNARY COMPLEXES WITH SERUM RESPONSE FACTOR ON THE SERUM RESPONSE ELEMENT OF THE FOS PROMOTER, Molecular and cellular biology, 17(10), 1997, pp. 5667-5678
Citation: T. Leveillard et B. Wasylyk, THE MDM2 C-TERMINAL REGION BINDS TO TAF(II)250 AND IS REQUIRED FOR MDM2 REGULATION OF THE CYCLIN-A PROMOTER, The Journal of biological chemistry, 272(49), 1997, pp. 30651-30661
Authors:
FITZSIMMONS D
HODSDON W
WHEAT W
MAIRA SM
WASYLYK B
HAGMAN J
Citation: D. Fitzsimmons et al., PAX-5 (BSAP) RECRUITS ETS PROTOONCOGENE FAMILY PROTEINS TO FORM FUNCTIONAL TERNARY COMPLEXES ON A B-CELL-SPECIFIC PROMOTER, Genes & development, 10(17), 1996, pp. 2198-2211
Authors:
LEVEILLARD T
ANDERA L
BISSONNETTE N
SCHAEFFER L
BRACCO L
EGLY JM
WASYLYK B
Citation: T. Leveillard et al., FUNCTIONAL INTERACTIONS BETWEEN P53 AND THE TFIIH COMPLEX ARE AFFECTED BY TUMOR-ASSOCIATED MUTATIONS, EMBO journal, 15(7), 1996, pp. 1615-1624
Citation: Mc. Dubspoterszman et al., MDM2 TRANSFORMATION IN THE ABSENCE OF P53 AND ABROGATION OF THE P107 G1 CELL-CYCLE ARREST, Oncogene, 11(11), 1995, pp. 2445-2449
Authors:
GIOVANE A
SOBIESZCZUK P
MIGNON C
MATTEI MG
WASYLYK B
Citation: A. Giovane et al., LOCATIONS OF THE ETS SUBFAMILY MEMBERS NET, ELK1, AND SAP1 (ELK3, ELK1, AND ELK4) ON 3 HOMOLOGOUS REGIONS OF THE MOUSE AND HUMAN GENOMES, Genomics, 29(3), 1995, pp. 769-772
Authors:
BRADFORD AP
CONRAD KE
WASYLYK C
WASYLYK B
GUTIERREZHARTMANN A
Citation: Ap. Bradford et al., FUNCTIONAL INTERACTION OF C-ETS-1 AND GHF-1 PIT-1 MEDIATES RAS ACTIVATION OF PITUITARY-SPECIFIC GENE-EXPRESSION - MAPPING OF THE ESSENTIAL C-ETS-1 DOMAIN/, Molecular and cellular biology, 15(5), 1995, pp. 2849-2857
Citation: Sl. Hahn et B. Wasylyk, THE ONCOPROTEIN V-ETS IS LESS SELECTIVE IN DNA-BINDING THAN C-ETS-1 DUE TO THE C-TERMINAL SEQUENCE CHANGE, Oncogene, 9(9), 1994, pp. 2499-2512
Authors:
MARSHALLHEYMAN H
ENGEL G
LJUNGDAHL S
SHOSHAN MC
SVENSSON C
WASYLYK B
LINDER S
Citation: H. Marshallheyman et al., TUMORIGENIC AND METASTATIC PROPERTIES OF 2 RAS-ONCOGENE TRANSFECTED RAT FIBROSARCOMA CELL-LINES DEFECTIVE IN C-JUN, Oncogene, 9(12), 1994, pp. 3655-3663
Authors:
GUTIERREZHARTMANN A
BRADFORD AP
CONRAD KE
WASYLYK B
Citation: A. Gutierrezhartmann et al., MOLECULAR MECHANISMS RESTRICTING ONCOGENE SIGNALING IN A PITUITARY-SPECIFIC MANNER, Clinical research, 42(2), 1994, pp. 10000204-10000204
Authors:
VONDERAHE D
NISCHAN C
KUNZ C
OTTE J
KNIES U
ODERWALD H
WASYLYK B
Citation: D. Vonderahe et al., ETS TRANSCRIPTION FACTOR-BINDING SITE IS REQUIRED FOR POSITIVE AND TNF-ALPHA-INDUCED NEGATIVE PROMOTER REGULATION, Nucleic acids research, 21(24), 1993, pp. 5636-5643